- Home
- ANEB vs ORMP Comparison
ANEB vs ORMP Comparison
Compare ANEB & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- ORMP
- Stock Information
- Founded
- ANEB 2020
- ORMP 2002
- Country
- ANEB United States
- ORMP United States
- Employees
- ANEB N/A
- ORMP N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- ORMP Health Care
- Exchange
- ANEB Nasdaq
- ORMP Nasdaq
- Market Cap
- ANEB 90.4M
- ORMP 90.2M
- IPO Year
- ANEB 2021
- ORMP N/A
- Fundamental
- Price
- ANEB $2.45
- ORMP $2.27
- Analyst Decision
- ANEB Buy
- ORMP Hold
- Analyst Count
- ANEB 2
- ORMP 1
- Target Price
- ANEB $8.00
- ORMP N/A
- AVG Volume (30 Days)
- ANEB 127.6K
- ORMP 94.3K
- Earning Date
- ANEB 11-12-2025
- ORMP 11-06-2025
- Dividend Yield
- ANEB N/A
- ORMP N/A
- EPS Growth
- ANEB N/A
- ORMP N/A
- EPS
- ANEB N/A
- ORMP N/A
- Revenue
- ANEB N/A
- ORMP $2,000,000.00
- Revenue This Year
- ANEB N/A
- ORMP N/A
- Revenue Next Year
- ANEB N/A
- ORMP N/A
- P/E Ratio
- ANEB N/A
- ORMP N/A
- Revenue Growth
- ANEB N/A
- ORMP N/A
- 52 Week Low
- ANEB $0.80
- ORMP $1.82
- 52 Week High
- ANEB $3.42
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- ANEB 52.56
- ORMP 53.79
- Support Level
- ANEB $2.33
- ORMP $2.17
- Resistance Level
- ANEB $2.58
- ORMP $2.45
- Average True Range (ATR)
- ANEB 0.16
- ORMP 0.05
- MACD
- ANEB -0.00
- ORMP -0.12
- Stochastic Oscillator
- ANEB 72.34
- ORMP 92.65
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.